Catecholamines, including dopamine, epinephrine, and norepinephrine, are considered
one of the most crucial subgroups of neurotransmitters in the central nervous system (CNS) …

Alzheimer's disease (AD) is a progressive neurological disease and the most common form
of dementia, affecting more than 10 million people all over the world. Clinically, AD is …

This study investigated the inhibitory mechanism of quercetin in acetylcholinesterase
(AChE) and its neuroprotective effects on β-amyloid25–35-induced oxidative stress injury in …

Mental disorders have a poor clinical prognosis and account for approximately 8% of the
global burden of disease. Some examples of mental disorders are anxiety and depression …

Alzheimer's disease (AD) stands as the predominant age-related neurodegenerative
disorder, for which efficacious treatment remains elusive. An auspicious avenue for this …

A novel aptasensor has been designed for quantitative monitoring of epinephrine (EP)
based on cerium metal–organic framework (CeMOF) loaded gold nanoparticles (AuNPs) …

Alzheimer's disease (AD) constitutes a major global health issue, characterized by
progressive neurodegeneration and cognitive impairment, for which no curative treatment is …

Dopamine (DA) is an important catecholamine neuromodulator that is present in the brain of
mammal, and changes of its level can be related to some neurological diseases such as …

Neurodegenerative diseases represent one of the utmost imperative well-being health
issues and apprehensions due to their escalating incidence of mortality. Natural derivatives …

Alzheimer is a severe memory and cognitive impairment neurodegenerative disease that is
the most common cause of dementia worldwide and characterized by the pathological …